O‐linked β‐N‐acetylglucosamine (O‐<scp>GlcNAc</scp>) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy

Bingxue Qi(University of Dundee), Li Kang(Lanzhou University of Technology)
Diabetic Medicine
September 16, 2024
Cited by 19


Related Papers